Filana Therapeutics, Inc. (FLNA) Operating income 2016–2025
Filana Therapeutics, Inc. (FLNA) annual operating income history from SEC filings — each fiscal year as reported.
-$95.4MFY2025 · since FY2016: -$15.0M → -$95.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$95.4M | +32.6% |
| FY2024 | -$141.4M | -33.5% |
| FY2023 | -$106.0M | -32.4% |
| FY2022 | -$80.0M | -143.5% |
| FY2021 | -$32.9M | -409.9% |
| FY2020 | -$6.4M | -30.0% |
| FY2019 | -$5.0M | +25.6% |
| FY2018 | -$6.7M | +44.2% |
| FY2017 | -$11.9M | +20.1% |
| FY2016 | -$15.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice